What one share of Rhythm Pharmaceuticals holds
We are a global, commercial-stage biopharmaceutical company dedicated to transforming the lives of patients living with rare neuroendocrine diseases. We are focused on advancing melanocortin-4 receptor (MC4R) agonists, including our lead asset, IMCIVREE® (setmelanotide), as precision medicines designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases.
Rhythm Pharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $3.56 |
|---|---|
| Profit | −$3.12 |
| Cash and investments | $0.95 |
| Debt | $1.54 |
| Book value | $1.50 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2015 | — | −$1.18 | $0.00 | −$0.69 | — | −$0.78 |
| 2016 | $0.00 | −$2.85 | $0.10 | −$2.38 | — | −$3.21 |
| 2017 | $0.00 | −$2.83 | $0.01 | −$2.23 | — | — |
| 2018 | $0.00 | −$2.39 | $0.02 | −$2.02 | — | $7.16 |
| 2019 | $0.00 | −$3.86 | $0.09 | −$3.46 | — | $6.39 |
| 2020 | $0.00 | −$3.04 | $0.00 | −$2.77 | — | $3.76 |
| 2021 | $0.06 | −$1.40 | $0.01 | −$2.95 | — | $5.65 |
| 2022 | $0.45 | −$3.48 | $0.01 | −$3.33 | — | $4.67 |
| 2023 | $1.34 | −$3.20 | $0.00 | −$2.36 | — | $2.86 |
| 2024 | $2.13 | −$4.34 | $0.00 | −$1.87 | — | $0.35 |
| 2025 | $2.92 | −$3.11 | $0.01 | −$1.79 | — | $2.07 |
Common questions about Rhythm Pharmaceuticals
How much does one share of Rhythm Pharmaceuticals earn?
Over the last 12 months, Rhythm Pharmaceuticals lost $3.12 for each share on $3.56 of sales.
Does Rhythm Pharmaceuticals pay a dividend?
Rhythm Pharmaceuticals didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Rhythm Pharmaceuticals’s book value per share?
Rhythm Pharmaceuticals’s book value is $1.50 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Rhythm Pharmaceuticals have?
Each share of Rhythm Pharmaceuticals has $0.95 of cash and investments and $1.54 of debt, as of June 30, 2026.
Has Rhythm Pharmaceuticals bought back shares?
Rhythm Pharmaceuticals’s share count rose about 537% from 2015 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.